America Stem Cell, Inc. announced today it has received clearance from FDA for its Phase I/IIa nationwide multi-center dual-umbilical cord transplantation study evaluating ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.
http://www.laboratorynetwork.com/doc/america-stem-cell-inc.-receives-fda-clearance-multi-center-nationwide-0001?atc~c=771+s=773+r=001+l=a
http://www.laboratorynetwork.com/doc/america-stem-cell-inc.-receives-fda-clearance-multi-center-nationwide-0001?atc~c=771+s=773+r=001+l=a
No comments:
Post a Comment